TherapeuticsMD, Inc. (TXMD)
Q1 2020 Earnings Conference Call
May 06, 2020 08:30 AM ET
Company Participants
Nichol Ochsner - Vice President of Investor Relations
Robert Finizio - Chief Executive Officer
Dawn Halkuff - Chief Commercial Officer
Mitchell Krassan - Chief Strategy & Performance Officer
Conference Call Participants
Jennifer Kim - Cantor Fitzgerald.
Stacy Ku - Cowen & Company
Annabel Samimy - Stifel
Doug Tsao - H.C. Wainwright
Ahu Demir - Noble Capital
Dana Flanders - Guggenheim
Presentation
Operator
Good morning, ladies and gentlemen. Thank you for joining us for the TherapeuticsMD First Quarter 2020 Financial